Reassessing the Role of Low PSA in Prognosis Across Grades of Prostate Cancer: A Cohort Study
Low PSA levels are notably linked to a heightened risk for both ACM and PCSM, irrespective of the grade of PCa being high or low. There is a need to initiate new studies that tackle novel diagnostics and therapeutics.
Authors
- Yong Zhang (ORCID: https://orcid.org/0000-0001-5768-5395)
- Hua Zhu (ORCID: https://orcid.org/0000-0002-4198-5809)
- Hong‐Lin Chen (ORCID: https://orcid.org/0000-0003-0147-6863)
- Yacheng Pan (ORCID: https://orcid.org/0009-0003-5083-6500)
- Fei‐Hong Hu (ORCID: https://orcid.org/0000-0003-2919-8631)
- Wei Wang (ORCID: https://orcid.org/0000-0001-7429-1013)
- Wei Zhang (ORCID: https://orcid.org/0000-0001-5857-7230)
- Zhan Chen (ORCID: https://orcid.org/0000-0002-2450-994X)
- Bing Zheng
- Cheng Shen (ORCID: https://orcid.org/0000-0002-6796-8855)
- Xinfeng Chen (ORCID: https://orcid.org/0000-0001-6992-1957)
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Second Affiliated Hospital of Nantong University
Publication Details
- Journal
- The Prostate
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1002/pros.24860
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00